Cas9

Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Fri, 10/4/24 - 09:24 am
Editas Medicine
Cas9
patents
Vertex Pharmaceuticals
gene editing
Editas and Vertex Ink Deal for Cas9 License for $50M Upfront
BioSpace
Wed, 12/13/23 - 10:07 pm
Editas Medicine
Vertex Pharmaceuticals
Cas9
Casgevy
Startup making Cas9 proxy for gene editing gets $55M to develop tools/software
Endpoints
Wed, 02/28/18 - 09:17 am
gene editing
Cas9
Inscripta
CRISPR
This Protein Could Change Biotech Forever
Forbes
Tue, 03/19/13 - 11:09 am
biotech
Cas9
DNA